Skip to main content
Clinical Trials/NCT03613038
NCT03613038CompletedNot Applicable

Understanding Communication and Cognitive Impairments in Neurodegenerative Disorders

University of Missouri-Columbia4 sites in 1 country100 target enrollmentStarted: July 15, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
4
Primary Endpoint
Duration

Study Overview

Brief Summary

The goal is to improve the fundamental knowledge about articulatory motor performance in people with Lou Gehrig's disease (also known as ALS) and Parkinson's disease (PD), in order to develop more sensitive assessments for progressive speech loss, which may lead to the improved timing of speech therapies.

Detailed Description

The long-term goal is to optimize dysarthria assessment by improving the early detection and tracking of articulatory performance in progressive dysarthrias. The short-term goal of the proposed cross-sectional study is to focus on ALS and PD and quantify articulatory kinematic performance as a function of phonetic complexity, which is experimentally manipulated based on theoretical principles of speech motor development. The research strategy is to use 3D electromagnetic articulography to examine phonetic complexity effects of single word stimuli at the articulatory kinematic level in 15 talkers each with preclinical, mild, and moderate dysarthria, relative to 45 controls. The central hypothesis is that as dysarthria severity increases the discrepancy in articulatory performance, indexed by movement speed, distance, coordination, and variability, between people with dysarthria and typical controls will significantly increase at a lower phonetic complexity level.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
19 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • May or may not have a neurological impairment.
  • Age range of 19-90 years.
  • Male or female.
  • Provide written consent before any study specific procedures are performed.
  • Have ability to comply with basic instructions.
  • Monolingual English speaker.
  • Have ability to partake in a 90 minute data collection.

Exclusion Criteria

  • Any speech, language, cognition, or hearing impairment prior to diagnosis of a neurodegenerative disease.
  • Anyone not appropriate for study participation, as deemed by the principal investigator.

Outcomes

Primary Outcomes

Duration

Time Frame: Up to 3 months after enrollment

Word duration (seconds) is the time between onset and offset of movement for each word.

Inter-articulator coordination

Time Frame: Up to 3 months after enrollment

Spatiotemporal coupling relations between articulators will be derived from vertical movements of the articulators using a covariance measure.

Peak movement speed

Time Frame: Up to 3 months after enrollment

Peak speed (millimeters/second) for each articulatory marker is the maximum value of the first-order derivative of each marker's Euclidean distance time-history.

Spatiotemporal movement variability (STI)

Time Frame: Up to 3 months after enrollment

STI is the most widely used metric to capture movement pattern variability during speech. To determine STI, the pattern of articulatory movements and the variability of that pattern over several repetitions of an utterance are examined.

Range of movement

Time Frame: Up to 3 months after enrollment

The convex hull represents the smallest convex set containing all the points in the 3D motion path.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mili Kuruvilla

Assistant Professor

University of Missouri-Columbia

Study Sites (4)

Loading locations...

Similar Trials

A Systematic Investigation of Phonetic... | Clinical Trial